India's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.02 Bn in 2022 to $0.24 Bn by 2030, registering a CAGR of 38% during the forecast period of 2022 - 2030. The market will be driven by the rising number of startups in AI diagnostic technology and government initiatives. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Qure AI. contact us at - info@insights10.com
Kenya Artificial Intelligence (AI) in Healthcare Market Analysis Sample ReportInsights10
Kenya's Artificial Intelligence (AI) in Healthcare Market is projected to grow from $4.83 Mn in 2022 to $101.48 Mn by 2030, registering a CAGR of 46.32% during the forecast period of 2022-30. The market will be driven by government initiatives and startups working to develop and implement AI solutions for healthcare. The market is segmented by healthcare components & by healthcare applications. To get a detailed report, contact us at - info@insights10.com
India 3D Printing Medical Devices Market Sample Report 2022 to 2030Insights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030.
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
India Telemedicine Market Analysis Sample ReportInsights10
The Indian telemedicine market is expected to witness growth from $1.1 Bn in 2022 to $5.1 Bn in 2030 with a CAGR of 21.2% for the forecasted year 2022-2030. Telemedicine services in India include tele-hospitals, mHealth, and tele-homes. Apollo Telehealth Services and Practo Technologies are some of the key players in the market. To get a detailed report, contact us at - info@insights10.com
The growth of healthcare sector in India will be a major boost for the device market. Rising incidence of lifestyle diseases due to changing lifestyles of Indian population and lack of physical exercise will be another feather in the hat. Other factors that will contribute to its glory are favorable demographics, increasing government focus on the sector, rapid spread of the health awareness and India emerging as the medical tourism hub of the world.
Contact us:
Niir Project Consultancy Services
106-E, Kamla Nagar, Near Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886, 8800733955
Mobile: +91-9811043595
Fax: +91-11-23841561
Website :
http://www.niir.org
http://www.entrepreneurindia.co
Tags
Disposable Glove Making Machine, Disposable medical syringe & needle production plant, Disposable Plastic Gloves, Disposable Plastic Syringe: Manufacturing Business Idea, Disposable Plastic Syringes Manufacturing Plant, Disposable Surgical Gowns Products, disposable surgical wear manufacturing, Disposable syringe - Small Industry, Disposable syringe making machine, Disposable syringe manufacturing plant, Disposable syringe manufacturing process, Disposable Syringe Plant, Glove manufacturing process,Healthcare Disposable Surgical Instruments, Hospital Surgical Items List, How to Manufacture Flexible PVC Blood Bags, How to manufacture Medical and Surgical Disposable products, How to manufacture Medical Disposable products, How to manufacture Surgical Disposable products, How to Start a Medical and Surgical Disposable Production Business, How to Start Medical and Surgical Disposable production Industry in India, Injection needle manufacturing process,List of disposable items used in hospitals, Manufacturing medical plastic like catheters and syringes, Materials for medical device packaging, Medical and Surgical Disposable products manufacturing Industry in India, Medical Based Small Scale Industries, Medical Blood Bag Production, Medical device manufacturing industry, Medical device manufacturing process, Medical Device Packaging, Medical Device Packaging Industry: Healthcare Packaging, Medical Devices and Surgical Disposables in India, Medical Disposable Blood Bag, Medical Disposable Products, Medical Disposable Products for hospital and surgical use, Medical disposables list, Medical disposables manufacturing in India, Medical Disposables and Surgical Disposables, Medical Glove Plant, Medical Products, Hospital Products, Surgical Products manufacturing, Medical Products: Surgical Blades, Urine Bags, Catheters, Most Profitable Surgical Disposable products manufacturing Business Ideas, New small scale ideas in Surgical Disposable products manufacturing industry, Process technology books, Project for startups, Specialty Surgical Gloves, Starting a Medical products manufacturing Business
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
India bariatric surgical devices market size, share & forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- India bariatric surgical devices market is expected to grow at a formidable rate during the forecast period. The India bariatric surgical devices market is driven by the growing diabetic population especially Type 2 diabetes. Additionally.
Report URL- https://www.techsciresearch.com/report/india-bariatric-surgical-devices-market/4557.html
Kenya Artificial Intelligence (AI) in Healthcare Market Analysis Sample ReportInsights10
Kenya's Artificial Intelligence (AI) in Healthcare Market is projected to grow from $4.83 Mn in 2022 to $101.48 Mn by 2030, registering a CAGR of 46.32% during the forecast period of 2022-30. The market will be driven by government initiatives and startups working to develop and implement AI solutions for healthcare. The market is segmented by healthcare components & by healthcare applications. To get a detailed report, contact us at - info@insights10.com
India 3D Printing Medical Devices Market Sample Report 2022 to 2030Insights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030.
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
India Telemedicine Market Analysis Sample ReportInsights10
The Indian telemedicine market is expected to witness growth from $1.1 Bn in 2022 to $5.1 Bn in 2030 with a CAGR of 21.2% for the forecasted year 2022-2030. Telemedicine services in India include tele-hospitals, mHealth, and tele-homes. Apollo Telehealth Services and Practo Technologies are some of the key players in the market. To get a detailed report, contact us at - info@insights10.com
The growth of healthcare sector in India will be a major boost for the device market. Rising incidence of lifestyle diseases due to changing lifestyles of Indian population and lack of physical exercise will be another feather in the hat. Other factors that will contribute to its glory are favorable demographics, increasing government focus on the sector, rapid spread of the health awareness and India emerging as the medical tourism hub of the world.
Contact us:
Niir Project Consultancy Services
106-E, Kamla Nagar, Near Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886, 8800733955
Mobile: +91-9811043595
Fax: +91-11-23841561
Website :
http://www.niir.org
http://www.entrepreneurindia.co
Tags
Disposable Glove Making Machine, Disposable medical syringe & needle production plant, Disposable Plastic Gloves, Disposable Plastic Syringe: Manufacturing Business Idea, Disposable Plastic Syringes Manufacturing Plant, Disposable Surgical Gowns Products, disposable surgical wear manufacturing, Disposable syringe - Small Industry, Disposable syringe making machine, Disposable syringe manufacturing plant, Disposable syringe manufacturing process, Disposable Syringe Plant, Glove manufacturing process,Healthcare Disposable Surgical Instruments, Hospital Surgical Items List, How to Manufacture Flexible PVC Blood Bags, How to manufacture Medical and Surgical Disposable products, How to manufacture Medical Disposable products, How to manufacture Surgical Disposable products, How to Start a Medical and Surgical Disposable Production Business, How to Start Medical and Surgical Disposable production Industry in India, Injection needle manufacturing process,List of disposable items used in hospitals, Manufacturing medical plastic like catheters and syringes, Materials for medical device packaging, Medical and Surgical Disposable products manufacturing Industry in India, Medical Based Small Scale Industries, Medical Blood Bag Production, Medical device manufacturing industry, Medical device manufacturing process, Medical Device Packaging, Medical Device Packaging Industry: Healthcare Packaging, Medical Devices and Surgical Disposables in India, Medical Disposable Blood Bag, Medical Disposable Products, Medical Disposable Products for hospital and surgical use, Medical disposables list, Medical disposables manufacturing in India, Medical Disposables and Surgical Disposables, Medical Glove Plant, Medical Products, Hospital Products, Surgical Products manufacturing, Medical Products: Surgical Blades, Urine Bags, Catheters, Most Profitable Surgical Disposable products manufacturing Business Ideas, New small scale ideas in Surgical Disposable products manufacturing industry, Process technology books, Project for startups, Specialty Surgical Gloves, Starting a Medical products manufacturing Business
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
India bariatric surgical devices market size, share & forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- India bariatric surgical devices market is expected to grow at a formidable rate during the forecast period. The India bariatric surgical devices market is driven by the growing diabetic population especially Type 2 diabetes. Additionally.
Report URL- https://www.techsciresearch.com/report/india-bariatric-surgical-devices-market/4557.html
Artificial Intelligence in Healthcare Market Forecast to 2024stella thomson
The report analyzes the artificial intelligence in healthcare market, By Component (Hardware, Software and Services), By Technology (Natural Language Processing, Machine Learning and Others), By End User (Healthcare Providers, Pharmaceutical Organizations and Others). Request free Sample of this Report @: http://azothanalytics.com/report/healthcare-pharma/artificial-intelligence-in-healthcare-market-world-market-analysis-by-component-hardware-software-services-technology-natural-language-processing-machine-learning-end-user-by-region-by-country-2019-edition-forecast-to-2024-r33199
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1
The Indian Home Healthcare market size was valued at USD 5.2 Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2028.
The increasing incidence of chronic diseases and the need for better primary and postoperative care has enhanced market growth Homecare in India. According to the World Health Organization (WHO), chronic and lifestyle diseases are expected to increase by XX% in India. Due to COVID-19 Pandemic, home healthcare services are considered to be safer and cost-effective alternative to hospital services for non-emergent cases. Home Healthcare in India is growing by 15-19% a year to touch $11-13 billion by 2025 from $5.4 billion.
Market Drivers
To avoid risk of getting infected, lack of personal care, to reduce the unnecessary hospital visits and high hospitalization costs are the major drivers that consumers are looking at home healthcare as the emerging solution. As the prevalence of lifestyle diseases, rising demand for quality and affordable care the need of Home Healthcare has increased. Home Healthcare Provides ICU services at 50% cheaper rate than the hospitals. ICU facility at Home with equipment and medical expertise ranges between Rs 7,500 to Rs 10,000 a day.
Type of Home Healthcare Services
The Home Healthcare market is further segmented by type of service into Physician/Primary Care, Nursing Care, Physical Occupational and Speech Therapy, Nutritional Support, Hospice & Palliative, Other Skilled Homecare Services. Primary care and Nursing care is dominating homecare services covering around XX% of Homecare Market in India.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
India Dental Care Market Analysis Sample ReportInsights10
India is one of the fastest-growing dental markets in the world. The India dental care market is projected to grow from $653 Mn in 2022 to $1,339 Mn in 2030 with a CAGR of 9.4% for the year 2022-2030. The market is segmented by product, treatment, and by end users. To get a detailed report, contact us at - info@insights10.com
Malaysia Healthcare Diagnostics Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Malaysia Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Global big data in healthcare market is projected to grow at CAGR of over 16% owing to increasing adoption of cloud analytics and storage.
Read: https://www.techsciresearch.com/report/big-data-in-healthcare-market/4009.html
India Cardiovascular Devices Market Size, Share, Trend, Analysis and Forecast...TechSci Research
According to #TechSci Research report, India Cardiovascular Devices Market is anticipated to grow with an estimated CAGR by 2027, on the grounds of increasing instances of cardiovascular diseases in the country.
Gain More Insight: https://bit.ly/3qxEOUw
Get Sample Report: https://bit.ly/3HmNuUp
Press Release: https://bit.ly/3eCXKLK
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
India Ophthalmology Therapeutics Market Report 2022 to 2030Insights10
Indian Ophthalmology Therapeutics Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028).
India Online Grocery Market - Industry Size, Share, Trends, Opportunity & For...TechSci Research
According to #TechSci Research report, India Online Grocery Market was valued USD3.95 Billion in 2021 and is anticipated to project robust growth by 2027, with an impressive CAGR of 33%.
Gain More Insight: https://bit.ly/3n3CmUC
Get Sample Report: https://bit.ly/3qdgdp4
Press Release: https://bit.ly/331KcY9
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
India IVD (Instruments & Reagents) Market, Share, Registration, Regulations &...iGATE RESEARCH
iGATE Research has released a research report on “India IVD (Instruments & Reagents) Market, Share, Registration, Regulations & Classification of IVD and Key Players Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=154
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Asia Pacific Bioinformatics Market Research Report: Forecast (2021-2026) - Ma...MarkNtel Advisors
Bioinformatics is a sub-discipline of biology and computer science that involves both hardware and software to obtain, store, and interpret large quantities of biological data.
Read More - https://www.marknteladvisors.com/research-library/asia-pacific-bioinformatics-market.html
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis...Insights10
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. To get a detailed report, contact us at - info@insights10.com
India biomedical waste management market Forecast 2024 | TechSci ResearchTechSci Research
According to www.techsciresearch.com latest report- India Biomedical Waste Management Market By Service (Recycling & Disposal), By Treatment Site (Offsite), By Region (South, West, North & East), Competition, Forecast & Opportunities, 2024.
Report More: https://www.techsciresearch.com/report/india-biomedical-waste-management-market/4321.html
Online retailing in India is bound to experience high growth rates on the back of rising internet penetration in the nation, growing disposable incomes, the smartphone revolution and also the dominance of younger population in the country’s demographics.
Rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices. In 2017, there were 3.8 million Australians aged 65 and over (comprising 15% of the total population). The number and proportion of older Australians are expected to continue to grow. The aging population demands more patient-centric healthcare services, which in return increases the demand for healthcare workers and agencies and is anticipated to drive market growth.
The growth of the aging population segment will boost the demand for healthcare and significantly increase the burden on governments and health systems as the aging population is more prone to chronic diseases. This will prove favorable to the market for home healthcare, which can enhance the overall reach of and access to healthcare while reducing unnecessary visits, hospital admissions & readmissions, and the time and costs involved in traveling to meet healthcare professionals.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
The global HR analytics market generated revenue of US$ 1.9 billion in 2020 and is expected to reach US$ 3.5 billion by 2025 with a CAGR of 12.6% in the forecast period. The HR analytics market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. The research report offers both qualitative and quantitative information on the global HR analytics market. In qualitative terms, the HR analytics market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-force model analysis and macro-economic factors, segment analysis, regional analysis at a granular level. Similarly, in quantitative terms, the report provides historical and forecast market numbers of HR analytics in various segments such as by component, deployment model, enterprise size & industry at global, regional, and country-level. Also, the report provides a detailed analysis of the market vendors and their product offerings. The report also covers details of the competitive market environment and includes information on the capabilities and competencies of market vendors.
Population Health Management Software Market.pdfsagarsingh443888
The global population health management software market generated revenue of US$ 20.9 billion in 2020 and is expected to reach US$ 34.1 billion by 2025 with a CAGR of 10.3% in the forecast period. The key drivers of population health management market growth are government mandates and support for healthcare IT technologies, the increased use of big data analytics, and the need to reduce rising healthcare costs. The population health management software market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. Also, the population health management software market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-fold model analysis, and macro-economic factors, at a granular level that lets readers understand the past and present market scenario and also helps to predict the potential growth of the population health management software market in the forecast period.
Advanced Analytics Market - Outlook (2017-21)ResearchFox
The immense growth of big data has made it tedious for traditional Business Intelligent tools to find the answer for particular business. Advanced analytics, by using the quantitative data, has the capability to drive changes and enhancement in business practices. Advance analytics tool helps to forecast future events, by gathering the data from various sources and applies the predictive modelling to foresee any deviation in business. The growth in big data and advancement in the data visualization, which helped to make it handy for any user, seems to be the key drivers for Advance Analytic market to grow.
The report titled Global Advanced Analytics Market showcases an in-depth analysis of the overall advance analytics market in terms of market size, segmentation for end-users, geographies, industry, deployment, competition, market metrics and service provider analysis.
The report brings about a detailed description of the developed and emerging markets globally, service providers analysis bracketed as Enterprise/Small and Medium Businesses along with market across each industry segment of advance analytics (Financial Services, IT & Telecommunication, Government & Defence, Consumer Goods & Retail, Transportation & Logistics, Healthcare, Manufacturing and Others) and deployment model (On-Premise and Cloud).
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
More Related Content
Similar to India Artificial Intelligence (AI) in Diagnostics Market Analysis Sample Report
Artificial Intelligence in Healthcare Market Forecast to 2024stella thomson
The report analyzes the artificial intelligence in healthcare market, By Component (Hardware, Software and Services), By Technology (Natural Language Processing, Machine Learning and Others), By End User (Healthcare Providers, Pharmaceutical Organizations and Others). Request free Sample of this Report @: http://azothanalytics.com/report/healthcare-pharma/artificial-intelligence-in-healthcare-market-world-market-analysis-by-component-hardware-software-services-technology-natural-language-processing-machine-learning-end-user-by-region-by-country-2019-edition-forecast-to-2024-r33199
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1
The Indian Home Healthcare market size was valued at USD 5.2 Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2028.
The increasing incidence of chronic diseases and the need for better primary and postoperative care has enhanced market growth Homecare in India. According to the World Health Organization (WHO), chronic and lifestyle diseases are expected to increase by XX% in India. Due to COVID-19 Pandemic, home healthcare services are considered to be safer and cost-effective alternative to hospital services for non-emergent cases. Home Healthcare in India is growing by 15-19% a year to touch $11-13 billion by 2025 from $5.4 billion.
Market Drivers
To avoid risk of getting infected, lack of personal care, to reduce the unnecessary hospital visits and high hospitalization costs are the major drivers that consumers are looking at home healthcare as the emerging solution. As the prevalence of lifestyle diseases, rising demand for quality and affordable care the need of Home Healthcare has increased. Home Healthcare Provides ICU services at 50% cheaper rate than the hospitals. ICU facility at Home with equipment and medical expertise ranges between Rs 7,500 to Rs 10,000 a day.
Type of Home Healthcare Services
The Home Healthcare market is further segmented by type of service into Physician/Primary Care, Nursing Care, Physical Occupational and Speech Therapy, Nutritional Support, Hospice & Palliative, Other Skilled Homecare Services. Primary care and Nursing care is dominating homecare services covering around XX% of Homecare Market in India.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
India Dental Care Market Analysis Sample ReportInsights10
India is one of the fastest-growing dental markets in the world. The India dental care market is projected to grow from $653 Mn in 2022 to $1,339 Mn in 2030 with a CAGR of 9.4% for the year 2022-2030. The market is segmented by product, treatment, and by end users. To get a detailed report, contact us at - info@insights10.com
Malaysia Healthcare Diagnostics Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Malaysia Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Global big data in healthcare market is projected to grow at CAGR of over 16% owing to increasing adoption of cloud analytics and storage.
Read: https://www.techsciresearch.com/report/big-data-in-healthcare-market/4009.html
India Cardiovascular Devices Market Size, Share, Trend, Analysis and Forecast...TechSci Research
According to #TechSci Research report, India Cardiovascular Devices Market is anticipated to grow with an estimated CAGR by 2027, on the grounds of increasing instances of cardiovascular diseases in the country.
Gain More Insight: https://bit.ly/3qxEOUw
Get Sample Report: https://bit.ly/3HmNuUp
Press Release: https://bit.ly/3eCXKLK
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
India Ophthalmology Therapeutics Market Report 2022 to 2030Insights10
Indian Ophthalmology Therapeutics Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028).
India Online Grocery Market - Industry Size, Share, Trends, Opportunity & For...TechSci Research
According to #TechSci Research report, India Online Grocery Market was valued USD3.95 Billion in 2021 and is anticipated to project robust growth by 2027, with an impressive CAGR of 33%.
Gain More Insight: https://bit.ly/3n3CmUC
Get Sample Report: https://bit.ly/3qdgdp4
Press Release: https://bit.ly/331KcY9
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
India IVD (Instruments & Reagents) Market, Share, Registration, Regulations &...iGATE RESEARCH
iGATE Research has released a research report on “India IVD (Instruments & Reagents) Market, Share, Registration, Regulations & Classification of IVD and Key Players Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=154
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Asia Pacific Bioinformatics Market Research Report: Forecast (2021-2026) - Ma...MarkNtel Advisors
Bioinformatics is a sub-discipline of biology and computer science that involves both hardware and software to obtain, store, and interpret large quantities of biological data.
Read More - https://www.marknteladvisors.com/research-library/asia-pacific-bioinformatics-market.html
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis...Insights10
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. To get a detailed report, contact us at - info@insights10.com
India biomedical waste management market Forecast 2024 | TechSci ResearchTechSci Research
According to www.techsciresearch.com latest report- India Biomedical Waste Management Market By Service (Recycling & Disposal), By Treatment Site (Offsite), By Region (South, West, North & East), Competition, Forecast & Opportunities, 2024.
Report More: https://www.techsciresearch.com/report/india-biomedical-waste-management-market/4321.html
Online retailing in India is bound to experience high growth rates on the back of rising internet penetration in the nation, growing disposable incomes, the smartphone revolution and also the dominance of younger population in the country’s demographics.
Rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices. In 2017, there were 3.8 million Australians aged 65 and over (comprising 15% of the total population). The number and proportion of older Australians are expected to continue to grow. The aging population demands more patient-centric healthcare services, which in return increases the demand for healthcare workers and agencies and is anticipated to drive market growth.
The growth of the aging population segment will boost the demand for healthcare and significantly increase the burden on governments and health systems as the aging population is more prone to chronic diseases. This will prove favorable to the market for home healthcare, which can enhance the overall reach of and access to healthcare while reducing unnecessary visits, hospital admissions & readmissions, and the time and costs involved in traveling to meet healthcare professionals.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
The global HR analytics market generated revenue of US$ 1.9 billion in 2020 and is expected to reach US$ 3.5 billion by 2025 with a CAGR of 12.6% in the forecast period. The HR analytics market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. The research report offers both qualitative and quantitative information on the global HR analytics market. In qualitative terms, the HR analytics market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-force model analysis and macro-economic factors, segment analysis, regional analysis at a granular level. Similarly, in quantitative terms, the report provides historical and forecast market numbers of HR analytics in various segments such as by component, deployment model, enterprise size & industry at global, regional, and country-level. Also, the report provides a detailed analysis of the market vendors and their product offerings. The report also covers details of the competitive market environment and includes information on the capabilities and competencies of market vendors.
Population Health Management Software Market.pdfsagarsingh443888
The global population health management software market generated revenue of US$ 20.9 billion in 2020 and is expected to reach US$ 34.1 billion by 2025 with a CAGR of 10.3% in the forecast period. The key drivers of population health management market growth are government mandates and support for healthcare IT technologies, the increased use of big data analytics, and the need to reduce rising healthcare costs. The population health management software market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. Also, the population health management software market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-fold model analysis, and macro-economic factors, at a granular level that lets readers understand the past and present market scenario and also helps to predict the potential growth of the population health management software market in the forecast period.
Advanced Analytics Market - Outlook (2017-21)ResearchFox
The immense growth of big data has made it tedious for traditional Business Intelligent tools to find the answer for particular business. Advanced analytics, by using the quantitative data, has the capability to drive changes and enhancement in business practices. Advance analytics tool helps to forecast future events, by gathering the data from various sources and applies the predictive modelling to foresee any deviation in business. The growth in big data and advancement in the data visualization, which helped to make it handy for any user, seems to be the key drivers for Advance Analytic market to grow.
The report titled Global Advanced Analytics Market showcases an in-depth analysis of the overall advance analytics market in terms of market size, segmentation for end-users, geographies, industry, deployment, competition, market metrics and service provider analysis.
The report brings about a detailed description of the developed and emerging markets globally, service providers analysis bracketed as Enterprise/Small and Medium Businesses along with market across each industry segment of advance analytics (Financial Services, IT & Telecommunication, Government & Defence, Consumer Goods & Retail, Transportation & Logistics, Healthcare, Manufacturing and Others) and deployment model (On-Premise and Cloud).
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
Patient - First Health With Generative AIInsights10
Patient-First Health With Generative AI Learn about the groundbreaking potential of #GenerativeAI in patient engagement, including its three broad categories of use cases. Understand why this innovation is poised to revolutionize patient interaction with their health and the crucial steps stakeholders must take to bring it to fruition. Don't miss this essential read by Insights10 for anyone passionate about the intersection of AI and healthcare! To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/42OOgWa
Vietnam In-Vitro Fertilization (IVF) Service Market AnalysisInsights10
This report presents a strategic analysis of Vietnam In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Turkey nutrition and supplements market will reach a value of $6.08 Mn from $3.05 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The nutritional supplements market in Turkey is primarily dominated by local players such as Form Labs, Hülya Şahin, and Solgar. To get a detailed report, contact us at - info@insights10.com
Spain Artificial Intelligence (AI) in Healthcare Market AnalysisInsights10
Spain's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.13 Bn in 2022 to $2.49 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-2030. The market will be driven by the government's support and increasing industry collaborations. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Methinks & IOMED. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. To get a detailed report, contact us at - info@insights10.com
The Kenya home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by indication and product. To get a detailed report, contact us at - info@insights10.com
Japan Nutritional Supplements Market Analysis.pdfInsights10
By 2030, it is anticipated that the Japan Nutrition and Supplements market will reach a value of $47.25 Bn from $23.71 Bn in 2022, growing at a CAGR of 9% during 2022-30. The market is primarily dominated by local players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto.To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Australian dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha Pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. To get a detailed report, contact us at - info@insights10.com
Australia Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. To get a detailed report, contact us at - info@insights10.com
Hong Kong Pharmaceutical Market AnalysisInsights10
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. To get a detailed report, contact us at - info@insights10.com
Mexico's connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the aging population, the rising prevalence of chronic diseases, and government support. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Support Services Market AnalysisInsights10
This report presents a strategic analysis of the Global Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
South Africa Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the South Africa Nutrition and Supplements market will reach a value of $xx Bn from $2.48 Bn Mn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. To get a detailed report, contact us at - info@insights10.com
Bulgaria Over The Counter (OTC) Pharmaceuticals Market AnalysisInsights10
Bulgaria's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 6.52% from 2022 to 2030 and will reach $227.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. The Radiotherapy Therapeutics Market in Japan is dominated by a few domestic players such as Hitachi, Mitsubishi Electric Corporation, and IHI Corporation. The radiotherapy market in Japan is segmented into different types, technologies, procedures, applications, and end-users.
To get a detailed report, contact us at - info@insights10.com
Generative AI Startup Scenario in India 2023Insights10
Let's see how Generative AI is revolutionizing Indian Healthcare. Imagine AI generating personalized treatment plans, predicting disease outbreaks, or even designing life-saving drugs. This isn't sci-fi, it's the thriving reality of India's Generative AI healthcare startups in 2023.
Startups like Tricuss, Niramai, PharmEasy, Qure.ai, and HealthifyMe are harnessing the power of generative models to tackle critical healthcare challenges.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Artificial Intelligence (AI) in Diagnostics Market Analysis Sample Report
1. India Artificial
Intelligence (AI) in
Diagnostics Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)
2. This report presents a strategic analysis of the India Artificial
Intelligence (AI) in Diagnostics Market and a forecast for its
development in the medium and long term. It provides a comprehensive
overview of the market value, dynamics, segmentation, types of clinical
diagnostics, point-of-care testing, main players, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the India Artificial Intelligence (AI) in
Diagnostics Market, and offers unmatched value, accuracy, and expert
insights
3. 3
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
4. 4
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
1. Artificial Intelligence (AI) in Diagnostics Overview 12-25
1.1. Overview
1.2. India Overview
1.3. Economic Overview: India
1.4. Artificial Intelligence (AI) in Diagnostics Market in India
1.5. Digital Health Market in India
1.6. Healthcare Scenario in India
1.7. Health Insurance Coverage: India
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 26-30
2.1 Market size and forecasts (Excel and Methodology)
5. 5
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Component Outlook
2.2.2. By Diagnosis Outlook
3. Market Dynamics 31-35
3.1. Market Growth Drivers
3.1.1. India Artificial Intelligence (AI) in Diagnostics Market Driver 1
3.1.2. India Artificial Intelligence (AI) in Diagnostics Market Driver 2
3.1.3. India Artificial Intelligence (AI) in Diagnostics Market Driver 3
3.2. Market Restraints
3.2.1. India Artificial Intelligence (AI) in Diagnostics Market Restraint 1
3.2.2. India Artificial Intelligence (AI) in Diagnostics Market Restraint 2
6. 6
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
3.2.3. India Artificial Intelligence (AI) in Diagnostics Market Restraint 3
4. Competitive Landscape 36-46
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Qure.ai
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Niramai
4.2.2.1. Overview
7. 7
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.2.2. Product Applications & Services
4.2.2.3. Recent Developments
4.2.2.4. Partnerships Ecosystem
4.2.2.5. Financials (Based on Availability)
4.2.3. Predible Health
4.2.3.1. Overview
4.2.3.2. Product Applications & Services
4.2.3.3. Recent Developments
4.2.3.4. Partnerships Ecosystem
4.2.3.5. Financials (Based on Availability)
4.2.4. OncoStem Diagnostics
4.2.4.1. Overview
8. 8
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.4.2. Product Applications & Services
4.2.4.3. Recent Developments
4.2.4.4. Partnerships Ecosystem
4.2.4.5. Financials (Based on Availability)
4.2.5. Eyestem Research
4.2.5.1. Overview
4.2.5.2. Product Applications & Services
4.2.5.3. Recent Developments
4.2.5.4. Partnerships Ecosystem
4.2.5.5. Financials (Based on Availability)
4.2.6. Netra.AI
4.2.6.1. Overview
9. 9
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.6.2. Product Applications & Services
4.2.6.3. Recent Developments
4.2.6.4. Partnerships Ecosystem
4.2.6.5. Financials (Based on Availability)
4.2.7. SigTuple
4.2.7.1. Overview
4.2.7.2. Product Applications & Services
4.2.7.3. Recent Developments
4.2.7.4. Partnerships Ecosystem
4.2.7.5. Financials (Based on Availability)
4.2.8. OncoDiscover
4.2.8.1. Overview
10. 10
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.8.2. Product Applications & Services
4.2.8.3. Recent Developments
4.2.8.4. Partnerships Ecosystem
4.2.8.5. Financials (Based on Availability)
4.2.9. Aindra Systems
4.2.9.1. Overview
4.2.9.2. Product Applications & Services
4.2.9.3. Recent Developments
4.2.9.4. Partnerships Ecosystem
4.2.9.5. Financials (Based on Availability)
4.2.10. Forus Health
4.2.10.1. Overview
11. 11
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.10.2. Product Applications & Services
4.2.10.3. Recent Developments
4.2.10.4. Partnerships Ecosystem
4.2.10.5. Financials (Based on Availability)
5. Reimbursement Scenario 47-54
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
5.4 Reimbursement Process – Medicare
5.5 Reimbursement Process - Medicaid
6. Methodology & Scope 55-77
12. India Artificial Intelligence (AI) in Diagnostics Market Analysis
1. Artificial Intelligence (AI) in Diagnostics Overview
13. 13
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.1 Statistics at a Glance: Global Utilization of Artificial Intelligence (AI) in
Diagnostics
Global scenario of Artificial
Intelligence (AI) in Diagnostics ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
$11 Mn
Was the worth of Artificial
Intelligence in healthcare
market in 2021
$188 Mn
Is the forecasted worth of
Artificial Intelligence in
healthcare market in 2030
47.6%
Was the share of North America in 2022, highest on the global level
Artificial Intelligence (AI) market in healthcare
37.5%
Is the expected CAGR of
Artificial Intelligence market
in Healthcare from 2023 to
2030
1 in 5
Healthcare organizations
worldwide in 2021 were in
early-stage initiatives of
using artificial intelligence
in their organizations
Illustrative
14. 14
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.1 Statistics at a Glance: Global Utilization of Artificial Intelligence (AI) in
Diagnostics (continued)
North America
~ Market Size of
$xx Bn
Europe
~Revenue to reach
$xx Bn by 2027
Asia
-xx% CAGR
Africa
~Market Size of $xx
Bn
Egypt Market
~$xx Mn Market
Illustrative
15. 15
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.2 India Overview
1.4 Bn
Was the population
of India, in 2022
28.4 years
Was the median
age in India, in
2022
$2.7 Tn
Is the Gross
Domestic Product
(GDP) in India in
2021
$84 Bn
Was the amount of
national health
expenditures of India in
2021
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Illustrative
16. 16
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.3 Economic Overview: India
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of India, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of India, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
17. 17
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.4 Statistics at a Glance: Scenario of Artificial Intelligence (AI) in Diagnostics
in India
Artificial Intelligence (AI) in Diagnostics in India
▪ Please be aware that this sample report is
intended to provide you with a brief overview
of the kind of information and analysis that
will be presented in the final report
▪ In this section you will get an understanding
of the topic, which includes the prevalence of
the disease, the application of medical
devices, new technology, and other details
related to the topic in India
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information related
to the topic or subject matter of interest
57%
Indians felt that doctors in
the country will regularly use
artificial intelligence to
decide on treatment for their
patients
$150 million
Is the amount invested in AI
start-ups in India since 2012
National Health Stack & National Digital Health Blueprint
are the recent documents to create a national digital health infrastructure
Triaging, detection and
diagnostics are the high
focus and high impact areas
for AI in healthcare in India
464
Is the number of AI in Healthcare
startups in India in 2023
Illustrative
18. 18
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.5 Digital Health in India
xx xx xx xx xx xx xx xx xx
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
India Digital Health Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Digital Health market in India, which includes the market size, current trends and
other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
19. 19
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.6 Healthcare Scenario in India
Artificial Intelligence (AI) in Diagnostics Drug Development Process: The process of developing a Artificial Intelligence (AI) in Diagnostics
drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the
Artificial Intelligence (AI) in Diagnostics drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treatingArtificial Intelligence (AI) in
Diagnostics
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the India market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative
20. 20
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.6 Healthcare Scenario: Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative
21. 21
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.7 Health Insurance Coverage: India
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative
22. 22
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.8 Budget of India Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
23. 23
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative
24. 24
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Acquisition $70.3 Mn Jan 2021
▪ Diagnostic chain Metropolis Healthcare will acquire Dr Ganesan's
Hitech Diagnostic Centre in a cash and stock combination deal,
to strengthen its leadership position in southern India
▪ By the acquisition, Metropolis will get an access to 31
laboratories, including three NABL- and ICMR-accredited
laboratories and 68 collection centers of Hitech
Partnership - Aug 2022
▪ HORIBA, SigTuple Partnership to accelerate adoption of
SigTuple’s AI100 across the Indian subcontinent
▪ SigTuple leverages AI & robotics, to automate the error-prone
and inefficient manual microscopic review of samples in
laboratories
Latest Deals In India
25. 25
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In India
27. 27
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
India Artificial Intelligence (AI) in Diagnostics Market Forecast, 2022-
2030 (in $Bn)
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In this section you will get an
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
and other details related to the topic
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Malaysia Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of India Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Malaysia Market Size (Bn
$)
61 74 84 87 91 95 99 106
Illustrative
28. 28
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
2.2 Snapshot of Artificial Intelligence (AI) in Diagnostics Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the India Artificial Intelligence (AI) in Diagnostics
Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Component Outlook
Software
Hardware
Services
Diagnosis Outlook
Cardiology
Oncology
Pathology
Radiology
Chest and Lung
Neurology
29. 29
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
India Artificial Intelligence (AI) in Diagnostics Market Share, By
Component Outlook (2022)
Software
Hardware
Services
▪ Services market in India is a significant
component of the overall Artificial
Intelligence (AI) in Diagnostics
treatment market
▪ It has the maximum market share in
India Artificial Intelligence (AI) in
Diagnostics market with approximately
xx%
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
2.2.1 Market Segmentation: By Component Outlook
Illustrative
30. 30
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
India Artificial Intelligence (AI) in Diagnostics Market Share, By
Diagnosis Outlook (2022)
Cardiology
Oncology
Pathology
Radiology
Chest and Lung
Neurology
2.2.3 Market Segmentation: By Diagnosis Outlook
▪ Hospitals have the maximum market
share in India Artificial Intelligence (AI)
in Diagnostics market with
approximately xx%
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
32. 32
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
3.1 Market growth drivers
▪ Incidence of Artificial Intelligence (AI) in Diagnostics is increasing in India,
with more than 1.8 Mn new Artificial Intelligence (AI) in Diagnostics cases
expected to be diagnosed in 2023
▪ This is driving the demand for Artificial Intelligence (AI) in Diagnostics
treatments and creating opportunities for growth in the Artificial
Intelligence (AI) in Diagnostics market
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
3.1.1 Incidence of Artificial Intelligence (AI) in Diagnostics is increasing in India
Utilization of Artificial Intelligence (AI) in
Diagnostics in India
Illustrative
33. 33
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
3.1 Market growth drivers (continued)
Top countries that are leveraging
technology in their fight against cancer
United States
Japan
Germany
South Korea
China
United Kingdom
France
Canada
Australia
Israel
Switzerland
Singapore
Sweden
Netherlands
Italy
Spain
Belgium
Denmark
Austria
Norway
3.1.2 Death rate from cancer in India has declined by 31% from 1992 to 2022, largely due to advances in technology
and treatment options
▪ India has a long history of investing in Artificial Intelligence
(AI) in Diagnostics research and treatment, and as a result,
has become a world leader in the field
▪ IT has a robust healthcare infrastructure, including world-
renowned research institutions, hospitals, and clinics, that
are dedicated to Artificial Intelligence (AI) in Diagnostics
treatment and research
▪ One of the key factors that has allowed India to stay ahead
in the field of Artificial Intelligence (AI) in Diagnostics
research and treatment is the high level of investment in
Artificial Intelligence (AI) in Diagnostics-related research
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
34. 34
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
3.1 Market growth drivers (continued)
Fundings from government and other
organizations
3.1.3 In 2021, the cancer Institute (NCI) received $6.4 Bn in funding from India federal government to support cancer
research and training programs
▪ India government provides significant support and funding
for cancer research and treatment, which is driving
innovation and growth in the Artificial Intelligence (AI) in
Diagnostics market
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Source Year Fund ($)
National Artificial
Intelligence (AI) in
Diagnostics Institute
(NCI)
2021 $ 6.4 Bn
Centers for Disease
Control and
Prevention (CDC)
2021 $ 501 Mn
American Artificial
Intelligence (AI) in
Diagnostics Society
(ACS)
2020 $ 150 Mn
Susan G. Komen 2020 $ 98 Mn
Illustrative
35. 35
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
3.2 Market restraints
3.2.1 In 2020, the
average cost of a new
cancer drug was over
$150,000 per year
▪ Cancer treatments can be very
expensive and can lead to
financial burden for patients and
healthcare systems
▪ Cost of cancer treatment varies
depending on the type of cancer,
stage of cancer, and treatment
options
▪ Some common cancer
treatments, such as
chemotherapy and radiation
therapy, can cost tens of
thousands of dollars
3.2.2 Average cost of
developing a new cancer
drug that is ultimately
approved by the FDA is over
$2.6 Bn
▪ Regulatory requirements for
cancer treatments can be very
stringent, which can slow down
the approval process and limit
access to new treatments
▪ Regulatory bodies, such as India
Food and Drug Administration
(FDA), require extensive clinical
trials and safety data before
approving new cancer
▪ This can be a lengthy and costly
process, which can delay the
availability of new treatments for
patients
3.2.3 Demand for cancer care is
expected to increase by 42% by
2025, while the supply of
oncologists is only expected to
increase by 28%
▪ There is a shortage of
oncologists in India, which can
limit access to cancer treatments
and create barriers to growth in
the cancer market
▪ Oncologists are physicians who
specialize in the diagnosis and
treatment of cancer
▪ With the aging population and
the increasing incidence of
cancer, there is a growing
demand for oncologists
▪ However, the supply of
oncologists is not keeping pace
with the demand
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
37. 37
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.1 Major Market Share
XX
Other
▪ India Artificial Intelligence (AI) in
Diagnostics market is a highly competitive
space, with many companies developing
and marketing Artificial Intelligence (AI) in
Diagnostics treatments
▪ Some of the top companies in India
Artificial Intelligence (AI) in Diagnostics
market based on revenue and market
share include
▪ Qure.ai is a Swiss multinational healthcare
company that develops and markets
Artificial Intelligence (AI) in Diagnostics
treatments, including targeted therapies
and immunotherapies
▪ In 2020, Qure.ai's oncology sales were
approximately $24 Bn, making it one of the
largest players in India Artificial Intelligence
(AI) in Diagnostics market
Revenue of Major players in India Artificial Intelligence
(AI) in Diagnostics Market ($ Mn)
Illustrative
38. 38
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
1 Qure.ai
3 Predible Health
5 Eyestem Research
7 SigTuple
9 Aindra Systems
2 Niramai
4 OncoStem Diagnostics
6 Netra.AI
8 OncoDiscover
Forus Health
10
Key Note:
39. 39
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.1 Qure.ai
Founded in: 2016
HQ: Maharashtra, India
Type: Private
Revenue: $3.6 Mn
Website: www.qure.ai.
▪ Provider of an AI-based decision support tool for diagnostic images
▪ Its radiology solution can diagnose disease from CT Scans, MRIs,
and X-rays as well as outline and quantify regions of interest such
as tumors or lung disease patterns
▪ It offers a digital pathology solution that can distinguish malignant
from benign biopsies, and grade a variety of tumor types
▪ Present in more than 70 countries
Care Areas
➢ Lung Cancer
➢ Tuberculosis
➢ Heart Failure
➢ Neurocritical Care
Products Indications
qXR AI for Chest X-rays
qER AI for Head CTs
qCT-Lung AI for Lung Nodules
qVH Beta AI for Ultrasound
qMSK AI for Musculoskeletal X-rays
Services offered Other information
Qure AI raised $40 Mn / Series C from HealthQuad and 3 other
investors in March 2022 to expand its presence in US and
Europe
Qure.ai has become the first AI health technology company to
have received endorsement from The College of Radiographers
(CoR) for conducting the Super User Training
40. 40
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.1 Qure.ai (continued)
Major Investors Major Partnerships
Partnerships Ecosystem
▪ Qure.ai has secured $40 million in a
funding round led by Novo Holdings
and HealthQuad
▪ HealthQuad claims to be India’s leading
digital health focused venture capital
fund with assets under management of
$200 Mn across two funds
▪ Qure.ai has secured $4.27 Mn from
SBRI Healthcare, in partnership with
the NHS cancer programme and NHS
Accelerated Access Collaborative
▪ The three organisations will
collaborate to establish a framework
for early diagnosis of lung cancer
▪ AstraZeneca has been partnering with
Qure.ai through the A.Catalyst
Network
▪ Qure.ai brings qXR, its deep-learning
AI technology software, to Fujifilm's
portable X-ray FDR Xair system,
enabling the device to analyse
radiographs
▪ Fujifilm and Qure’s technology will
deliver a support tool to assist the
care providers for accurate diagnosis
faster
41. 41
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.1 Qure.ai (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Collaboration - April 2023
▪ The collaboration between Qure.ai and Nuance helps make
cutting-edge imaging AI easily integrated and accessible to
different stakeholders in the US healthcare system
Investment $ 329,000 April 2022
▪ The SAMRIDH Healthcare Blended Financing Facility, supported
by the U.S. Agency for International Development (USAID) and
implemented by IPE Global, has committed to Qure.ai to scale
Artificial Intelligence (AI)-enabled chest X-ray screening software,
qXR, in 50 sites across more than 15 Indian states
Latest Deals - Mergers and Acquisitions
42. 42
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.1 Qure.ai (continued)
Revenues ($Bn), 2020-2030
▪ According to Qure.ai's 2020 financial
report, the company had revenue of $3.6
Mn in 2022
▪ Qure.ai is a Venture Capital-Backed
company
▪ Revenue generated by Qure.ai in 2022
reflects the company's continued growth
and success in the healthcare industry
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative
43. 43
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for
Artificial
Intelligence (AI)
in Diagnostics
Recent Activity / Press Coverage
Illustrative
44. 44
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative
45. 45
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.2 Company 2 (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative
46. 46
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative
48. 48
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.1 Reimbursement Regulation
The reimbursement scenario in the India Artificial Intelligence (AI) in Diagnostics
Market is complex and can vary depending on the specific treatment, setting of
care, and insurance coverage. Here are some key points to consider:
▪ Medicare:
o Medicare is a federal health insurance program for people aged 65 and
older, as well as people with certain disabilities or health conditions
o Medicare covers many Artificial Intelligence (AI) in Diagnostics
treatments, including chemotherapy, radiation therapy, and some
immunotherapies
o However, coverage can be subject to strict guidelines and restrictions,
such as the requirement for prior authorization
▪ Medicaid:
o Medicaid is a joint federal-state program that provides health insurance
for people with low incomes
o Medicaid coverage for Artificial Intelligence (AI) in Diagnostics
treatments can vary by state, and may be subject to limits on the
amount and type of treatment covered
▪ Private Insurance:
o Private insurance coverage for Artificial Intelligence (AI) in Diagnostics
treatments can also vary widely depending on the insurer and the
specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Medicare and Medicaid together provide
health insurance coverage for more than
4 in 10 Americans
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative
49. 49
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.1 Reimbursement Regulation (continued)
▪ Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to Artificial Intelligence (AI) in Diagnostics treatments
by requiring insurers to cover certain preventive services, including Artificial Intelligence (AI) in Diagnostics screenings,
without co-pays or deductibles
o It also includes protections for people with pre-existing conditions, such as Artificial Intelligence (AI) in Diagnostics
▪ Reimbursement for New Treatments:
o Reimbursement for new Artificial Intelligence (AI) in Diagnostics treatments can be a complex and lengthy process, as
insurers and government programs often require evidence of safety and effectiveness before providing coverage
o This can create challenges for companies developing and marketing new treatments
▪ Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the
value of treatments rather than simply the volume of treatments
o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
50. 50
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the India healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
51. 51
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.2 Reimbursement Process in Diagnostics
The reimbursement process in the India healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
52. 52
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.3 Reimbursement Process for Treatment
The reimbursement process in the India healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative
53. 53
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.4 Reimbursement Process - Medicare
Medicare
Population Covered
▪ 100% population is covered under this scheme
▪ Citizen’s contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an
individuals Medicare account
Provider Restrictions/
Selection
Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicare account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for Artificial Intelligence (AI) in Diagnostics up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal dialysis up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative
54. 54
A Sample Report on India Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
5.5 Reimbursement Process - Medicaid
Medicaid
Population Covered
▪ 38% population is covered under this scheme
▪ Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease
Provider Restrictions/
Selection
Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicaid account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for Artificial Intelligence (AI) in Diagnostics up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal dialysis up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative
56. Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the India dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
57. Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research
58. Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary
59. Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
60. 2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period
62. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust
63. www.insights10.com
A large database of over 30,000 syndicated
market research reports in Digital Health and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions
64. Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com
65. Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com
71. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
72. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
73. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
74. What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read
76. “The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO
77. Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the India, India, Middle
East and APAC regions. His
primary area of interest is
Customer and Market Strategy,
Market Access, and Digital Health
with special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager